Northern Trust Corp Soleno Therapeutics Inc Transaction History

Northern Trust Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$0.97 - $1.32 $484,884 - $659,842	-499,881 Reduced 82.58%	105,481 $120,000
Q1 2021 May 12, 2021	SELL	$1.24 - $3.3 $79,667 - $212,018	-64,248 Reduced 9.59%	605,362 $763,000
Q4 2020 Feb 11, 2021	BUY	$1.61 - $2.23 $67,497 - $93,490	41,924 Added 6.68%	669,610 $1.29 Million
Q3 2020 Nov 16, 2020	BUY	$1.71 - $2.51 $434,531 - $637,821	254,112 Added 68.02%	627,686 $1.58 Million
Q2 2020 Aug 14, 2020	BUY	$1.77 - $4.23 $577,446 - $1.38 Million	326,241 Added 689.25%	373,574 $830,000
Q1 2020 May 14, 2020	BUY	$1.64 - $3.85 $38,892 - $91,302	23,715 Added 100.41%	47,333 $113,000
Q4 2019 Feb 14, 2020	BUY	$1.35 - $2.95 $31,884 - $69,673	23,618 New	23,618 $69,000
Q2 2019 Aug 13, 2019	SELL	$1.93 - $2.95 $22,445 - $34,308	-11,630 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$1.56 - $3.1 $18,142 - $36,053	11,630 New	11,630 $27,000

Ticker SLNO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,101,250
Market Cap $375M
Description
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing P...

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

Stay updated on Northern Trust Corp with notifications on news.